141 related articles for article (PubMed ID: 33112820)
1. Akt1 genetic variants confer increased susceptibility to thyroid cancer.
Crezee T; Petrulea M; Piciu D; Jaeger M; Smit JWA; Plantinga TS; Georgescu CE; Netea-Maier R
Endocr Connect; 2020 Nov; 9(11):1065-1074. PubMed ID: 33112820
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
3. Association of NF-κB polymorphisms with clinical outcome of non-medullary thyroid carcinoma.
Plantinga TS; Petrulea MS; Oosting M; Joosten LAB; Piciu D; Smit JW; Netea-Maier RT; Georgescu CE
Endocr Relat Cancer; 2017 Jul; 24(7):307-318. PubMed ID: 28428267
[TBL] [Abstract][Full Text] [Related]
4. Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer.
Li Q; Yang J; Yu Q; Wu H; Liu B; Xiong H; Hu G; Zhao J; Yuan X; Liao Z
Clin Cancer Res; 2013 Nov; 19(22):6252-60. PubMed ID: 24077347
[TBL] [Abstract][Full Text] [Related]
5. Association between single nucleotide polymorphisms in the PI3K/AKT/mTOR pathway and bladder cancer risk in a sample of Iranian population.
Bizhani F; Hashemi M; Danesh H; Nouralizadeh A; Narouie B; Bahari G; Ghavami S
EXCLI J; 2018; 17():3-13. PubMed ID: 29383014
[TBL] [Abstract][Full Text] [Related]
6. Association of PI3K/AKT/mTOR pathway genetic variants with type 2 diabetes mellitus in Chinese.
Yin X; Xu Z; Zhang Z; Li L; Pan Q; Zheng F; Li H
Diabetes Res Clin Pract; 2017 Jun; 128():127-135. PubMed ID: 28477532
[TBL] [Abstract][Full Text] [Related]
7. Study on the association between PI3K/AKT/mTOR signaling pathway gene polymorphism and susceptibility to gastric cancer.
Qi L; Sun K; Zhuang Y; Yang J; Chen J
J BUON; 2017; 22(6):1488-1493. PubMed ID: 29332342
[TBL] [Abstract][Full Text] [Related]
8. Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways.
Srivastava A; Kumar A; Giangiobbe S; Bonora E; Hemminki K; Försti A; Bandapalli OR
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31614935
[TBL] [Abstract][Full Text] [Related]
9. Gene polymorphisms in the PI3K/AKT/mTOR signaling pathway contribute to prostate cancer susceptibility in Chinese men.
Liu T; Gulinaer A; Shi X; Wang F; An H; Cui W; Li Q
Oncotarget; 2017 Sep; 8(37):61305-61317. PubMed ID: 28977864
[TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility to hereditary non-medullary thyroid cancer.
Kamani T; Charkhchi P; Zahedi A; Akbari MR
Hered Cancer Clin Pract; 2022 Mar; 20(1):9. PubMed ID: 35255942
[TBL] [Abstract][Full Text] [Related]
11. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations.
Hafner C; Landthaler M; Vogt T
Exp Dermatol; 2010 Aug; 19(8):e222-7. PubMed ID: 20557351
[TBL] [Abstract][Full Text] [Related]
12. AKT inhibition in the central nervous system induces signaling defects resulting in psychiatric symptomatology.
Tsimberidou AM; Skliris A; Valentine A; Shaw J; Hering U; Vo HH; Chan TO; Armen RS; Cottrell JR; Pan JQ; Tsichlis PN
Cell Biosci; 2022 May; 12(1):56. PubMed ID: 35525984
[TBL] [Abstract][Full Text] [Related]
13. Identification of Rare Variants Predisposing to Thyroid Cancer.
Wang Y; Liyanarachchi S; Miller KE; Nieminen TT; Comiskey DF; Li W; Brock P; Symer DE; Akagi K; DeLap KE; He H; Koboldt DC; de la Chapelle A
Thyroid; 2019 Jul; 29(7):946-955. PubMed ID: 30957677
[No Abstract] [Full Text] [Related]
14. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
Li X; Zhang R; Liu Z; Li S; Xu H
Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
[TBL] [Abstract][Full Text] [Related]
15. Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.
Le Rhun E; Bertrand N; Dumont A; Tresch E; Le Deley MC; Mailliez A; Preusser M; Weller M; Revillion F; Bonneterre J
Eur J Cancer; 2017 Dec; 87():189-198. PubMed ID: 29103666
[TBL] [Abstract][Full Text] [Related]
16. Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
De Marco C; Laudanna C; Rinaldo N; Oliveira DM; Ravo M; Weisz A; Ceccarelli M; Caira E; Rizzuto A; Zoppoli P; Malanga D; Viglietto G
PLoS One; 2017; 12(6):e0178865. PubMed ID: 28662101
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
18. PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel.
Pfisterer K; Fusi A; Klinghammer K; Knödler M; Nonnenmacher A; Keilholz U
Head Neck; 2015 Apr; 37(4):471-8. PubMed ID: 24421178
[TBL] [Abstract][Full Text] [Related]
19. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway.
Zhang P; Wang C; Ma T; You S
Onco Targets Ther; 2015; 8():3305-13. PubMed ID: 26635480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]